Q32 Bio Inc (QTTB) — Financial Flexibility Index
Q32 Bio Inc (QTTB) has a Financial Flexibility Index of -0.37x as of March 2026. Free cash flow of $-6.34 Million (operating CF $-6.34 Million minus capex $0.00) represents 0% of total liabilities ($17.36 Million). Check Q32 Bio Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Q32 Bio Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Q32 Bio Inc across 10 annual periods. See Q32 Bio Inc (QTTB) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Q32 Bio Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Q32 Bio Inc. For the full company profile including market capitalisation, see Q32 Bio Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.70x | $-33.54 Million | $-33.54 Million | $19.76 Million | ▼ -117.4% |
| 2024 | -0.78x | $-67.64 Million | $-67.72 Million | $86.66 Million | ▼ -861.4% |
| 2023 | -0.08x | $-18.67 Million | $-18.68 Million | $229.98 Million | ▼ -84.5% |
| 2022 | -0.04x | $-8.47 Million | $-10.96 Million | $192.49 Million | ▲ +98.3% |
| 2021 | -2.55x | $-107.36 Million | $-109.75 Million | $42.07 Million | ▼ -90.8% |
| 2020 | -1.34x | $-90.60 Million | $-94.33 Million | $67.74 Million | ▼ -0.1% |
| 2019 | -1.34x | $-69.53 Million | $-91.36 Million | $52.06 Million | ▼ -375.4% |
| 2018 | -0.28x | $-17.62 Million | $-42.56 Million | $62.74 Million | ▼ -230.6% |
| 2017 | 0.22x | $8.44 Million | $6.48 Million | $39.22 Million | ▲ +122.3% |
| 2016 | -0.97x | $-6.49 Million | $-8.48 Million | $6.72 Million | — |